NVDA+2.54%AAPL+1.32%GOOGL−1.62%MSFT+0.20%AMZN−0.10%TSM+1.60%SPCX+7.79%META+0.47%
StockVS

NASDAQ · Medical Devices · USD

Orthofix Medical Inc. (OFIX) Stock Analysis

Orthofix Medical Inc. (OFIX) is a Medical Devices stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

OFIX

$9.74

−$0.11 (−1.12%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare OFIX with… →

OFIX Key Statistics

As of Oct 21, 2026
Trading
Open
$9.71
Previous Close
$9.85
Day's Range
9.64–9.94
52-Week Range
8.50–16.99
Volume
398.96K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.62
Valuation
Market Cap
$393.71M
P/E Ratio
unprofitable
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
26.32
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
48.83
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
0.47
EPS (ttm)Profit attributable to each share over the last twelve months.
−1.52
Financials (FY)
Revenue (FY)
$822.31M+2.85%
Net Income (FY)
−$92.19M
Profit marginThe share of revenue left as profit after all costs and taxes.
−7.41%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
40.42M
1-Year Return
−38.04%
Dividend and dates
Earnings Date
November 3, 2026estimated
Avg Volume
372.63K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, OFIX closed at $9.74, −38.04% over 1 year.

Orthofix Medical Inc. (OFIX) has a market capitalization of $393.71M.

In fiscal 2025, OFIX reported revenue of $822.31M.

OFIX Stock Return by Calendar Year

Orthofix Medical Inc. (OFIX) 10-year return: what $10,000 became

1 year
$10,000 $6,196
−38.04%
5 years
$10,000 $2,694
−73.06%
10 years
$10,000 $2,461
−75.39%

If you had invested $10,000 in Orthofix Medical Inc. (OFIX) 10 years ago, at the close on October 21, 2016, it would have been worth $2,461 at the close on October 21, 2026: −75.39% in total, −13.08% a year. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−35.75%
2025−13.17%
2024+29.53%
2023−34.34%
2022−33.97%
2021−27.66%
2020−6.93%
2019−12.02%
2018−4.04%
2017+51.19%
2016 (partial year)−14.81%

As of October 21, 2026.

OFIX Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$822.31M−$92.19M−11.2%
2024$799.49M−$126.00M−15.8%
2023$746.64M−$151.40M−20.3%
2022$460.71M−$19.75M−4.3%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$822.31M$566.02M−$82.57M−$92.19M−11.2%
2024$799.49M$545.89M−$77.72M−$126.00M−15.8%
2023$746.64M$486.27M−$141.76M−$151.40M−20.3%
2022$460.71M$337.17M−$28.87M−$19.75M−4.3%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

OFIX Valuation vs Medical Devices Median

Median of 145 stocks
MetricOFIXMedical Devices medianvs median
P/S ratio0.472.530.2x the median
Profit margin−7.41%−14.78%7.4 pts above

Medians across 145 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

All 7 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values Orthofix Medical Inc. (OFIX) at $393.71M. The company sits in the Healthcare sector, in the Medical Devices industry. Headcount on file is 1,605.

The 52-week range on file runs from $8.50 to $16.99. The most recent close on file for OFIX is $9.74, dated October 21, 2026. That is −$0.11 (−1.12%) against the previous close. The latest close sits 14.59% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $822.31M. Against the prior fiscal year total of $799.49M, that is a change of +2.85%. The same year closed with a net loss of $92.19M. Profit margin runs at −7.41%. That is 7.4 percentage points above the Medical Devices median of −14.78%. Earnings per share on a trailing basis come to −1.52.

Across the 4 fiscal years on file, revenue moves from $460.71M in 2022 to $822.31M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. On forward earnings the ratio is 26.32. The PEG ratio, which sets the P/E against expected earnings growth, reads 48.83. The price-to-sales ratio is 0.47. On price-to-sales that is 0.2 times the Medical Devices median of 2.53. The medians here are taken across 145 Medical Devices companies that report the metric.

Beta against the wider market is reported at 0.62. Daily returns over the trailing 10 years annualize to a volatility of 41.11%. The trailing one-year total return is −38.04%. Measured over 10 years, that is −13.08% a year compounded.

Growth & Income

The record shows no dividend for OFIX.

The strongest complete calendar year on file is 2017 at +51.19%; the weakest is 2023 at −34.34%. Of the 9 complete calendar years on file, 2 finished higher. 2026 is still running; the total return is −35.75% year to date.

Peer Comparison

Orthofix Medical Inc. (OFIX) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Orthofix Medical Inc. OFIX $393.71M —
Abbott Laboratories ABT $173.92B 32.4
Medtronic plc. MDT $119.00B 22.9
Stryker Corporation SYK $114.15B 30.8

The Medical Devices industry average P/E ratio is 27.1x. Orthofix Medical Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$173.92B

 MDT

Medtronic plc.

$119.00B

 SYK

Stryker Corporation

$114.15B

 BSX

Boston Scientific Corporation

$64.33B

 EW

Edwards Lifesciences Corporation

$50.95B

 GEHC

GE HealthCare Technologies Inc.

$31.17B
View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

 JNJ

Johnson & Johnson

$621.22B

 ABBV

AbbVie Inc.

$503.27B

 UNH

UnitedHealth Group Incorporated

$374.30B

 MRK

Merck & Co., Inc.

$369.78B
View all Healthcare stocks →

About Orthofix Medical Inc.

Orthofix Medical Inc., together with its subsidiaries, operates as a medical technology company in the United States, Italy, the United Kingdom, France, Germany, Brazil, and internationally. It operates through two segments, Global Spine and Global Limb Reconstruction. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulation devices that enhance bone fusion; designs, develops, and markets a portfolio of spine fixation implant products for use throughout the spinal column; and offers bone graft substitutes, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers in various forms with supporting graft delivery solutions to treat various spinal, orthopedic, and dental conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations; and 7D FLASH Navigation System, a navigation platform for spinal and cranial procedures. The Global Limb Reconstruction segment offers products and solutions for the underserved limb reconstruction market, including deformity correction, limb lengthening, complex fracture management, and limb preservation. This segment also designs, develops, and markets external and internal fixation limb reconstruction products that are coupled with enabling digital technologies to support the entire patient care continuum. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, healthcare providers, ambulatory surgery centers, and out-patient hospitals. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in July 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.

Visit website →